Chicago-based Northwestern Medicine recorded an operating income of $126.3 million (4.2% operating margin) in the third quarter of fiscal 2026, up from an operating income of $111 million (4.1% margin) during the same period last year, according to its July 15 financial report.
Northwestern Medicine reported total operating revenue of $3 billion during the three months ended May 31, up from $2.7 billion during the same period last year. Patient service revenue was $2.7 billion, up from $2.5 billion.
Total operating expenses were $2.9 billion in Q3 2026, up from $2.6 billion during the same period last year. Salaries and employee benefits totaled $1.4 billion, up from $1.3 billion. Supply expenses totaled $752.8 million, up from $655.4 million. Purchased services totaled $263 million, up from $237.4 million.
Northwestern Medicine reported a net income of $577.8 million in Q3 2026, up from $220.3 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
